Publication | Closed Access

Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the assessment of the safety of a new thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction

ThrombosisCardiovascular DiseaseAtherosclerosisMedicineUnfractionated HeparinOne-year Follow-up ResultsPharmacotherapyCoagulopathyPlatelet AntagonistPharmacologyAnticoagulantCardiologyAcute Myocardial InfarctionMyocardial Infarction